Kurs
-17,73%
Likviditet
50,8 MSEK
Kalender
Tid* | ||
2026-02-19 | 08:00 | Bokslutskommuniké 2025 |
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-06 | - | Årsstämma |
2025-04-16 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-20 | 08:00 | Bokslutskommuniké 2024 |
2024-10-24 | - | Kvartalsrapport 2024-Q3 |
2024-08-29 | - | Extra Bolagsstämma 2024 |
2024-07-18 | - | Kvartalsrapport 2024-Q2 |
2024-05-06 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2024-05-06 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2024-05-03 | - | Årsstämma |
2024-04-18 | - | Kvartalsrapport 2024-Q1 |
2024-02-22 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-20 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2023-05-08 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2023-05-05 | - | Årsstämma |
2023-04-20 | - | Kvartalsrapport 2023-Q1 |
2023-02-23 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-07-22 | - | Kvartalsrapport 2022-Q2 |
2022-05-09 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2022-05-09 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2022-05-06 | - | Årsstämma |
2022-04-22 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-10-27 | - | Kvartalsrapport 2021-Q3 |
2021-07-23 | - | Kvartalsrapport 2021-Q2 |
2021-04-26 | - | X-dag ordinarie utdelning ADDV B 0.02 SEK |
2021-04-26 | - | X-dag ordinarie utdelning ADDV A 0.02 SEK |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-04-23 | - | Årsstämma |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-10-23 | - | Kvartalsrapport 2020-Q3 |
2020-07-24 | - | Kvartalsrapport 2020-Q2 |
2020-04-27 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2020-04-27 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2020-04-24 | - | Årsstämma |
2020-04-24 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-10-22 | - | Kvartalsrapport 2019-Q3 |
2019-07-23 | - | Kvartalsrapport 2019-Q2 |
2019-04-26 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2019-04-26 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2019-04-25 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-03-12 | - | Extra Bolagsstämma 2019 |
2019-02-21 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-07-26 | - | Kvartalsrapport 2018-Q2 |
2018-05-04 | - | Kvartalsrapport 2018-Q1 |
2018-04-27 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2018-04-27 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2018-04-26 | - | Årsstämma |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-10-31 | - | Kvartalsrapport 2017-Q3 |
2017-07-26 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | Kvartalsrapport 2017-Q1 |
2017-04-28 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2017-04-28 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2017-04-27 | - | Årsstämma |
2017-02-23 | - | Bokslutskommuniké 2016 |
2016-11-14 | - | Kvartalsrapport 2016-Q3 |
2016-08-18 | - | Kvartalsrapport 2016-Q2 |
2016-05-23 | - | Kvartalsrapport 2016-Q1 |
2016-04-27 | - | X-dag ordinarie utdelning ADDV B 0.00 SEK |
2016-04-27 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2016-04-26 | - | Årsstämma |
2016-02-22 | - | Bokslutskommuniké 2015 |
2015-11-10 | - | Kvartalsrapport 2015-Q3 |
2015-08-17 | - | Kvartalsrapport 2015-Q2 |
2015-05-22 | - | Kvartalsrapport 2015-Q1 |
2015-04-27 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2015-04-24 | - | Årsstämma |
2015-02-19 | - | Bokslutskommuniké 2014 |
2014-11-05 | - | Kvartalsrapport 2014-Q3 |
2014-08-15 | - | Kvartalsrapport 2014-Q2 |
2014-05-21 | - | Kvartalsrapport 2014-Q1 |
2014-04-10 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2014-04-09 | - | Årsstämma |
2014-02-20 | - | Bokslutskommuniké 2013 |
2013-11-05 | - | Kvartalsrapport 2013-Q3 |
2013-08-08 | - | Kvartalsrapport 2013-Q2 |
2013-05-20 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2013-05-17 | - | Årsstämma |
2013-05-14 | - | Kvartalsrapport 2013-Q1 |
2013-02-21 | - | Bokslutskommuniké 2012 |
2012-11-06 | - | Kvartalsrapport 2012-Q3 |
2012-08-09 | - | Kvartalsrapport 2012-Q2 |
2012-05-14 | - | Kvartalsrapport 2012-Q1 |
2012-04-02 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2012-03-30 | - | Årsstämma |
2012-02-23 | - | Bokslutskommuniké 2011 |
2011-11-04 | - | Kvartalsrapport 2011-Q3 |
2011-08-10 | - | Kvartalsrapport 2011-Q2 |
2011-05-05 | - | Kvartalsrapport 2011-Q1 |
2011-04-06 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2011-04-04 | - | Årsstämma |
2011-02-07 | - | Bokslutskommuniké 2010 |
2010-11-04 | - | Kvartalsrapport 2010-Q3 |
2010-08-12 | - | Kvartalsrapport 2010-Q2 |
2010-05-21 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2010-05-20 | - | Årsstämma |
2010-05-06 | - | Kvartalsrapport 2010-Q1 |
2009-09-25 | - | X-dag ordinarie utdelning ADDV A 0.00 SEK |
2009-09-24 | - | Årsstämma |
2009-09-17 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
The board of directors of ADDvise Group announces today that the chairman of the board, Staffan Torstensson, is appointed CEO of the company, effective September 1, 2024. In light of this transition, the board will convene an extraordinary general meeting in the near future to elect Per Åhlgren as board member and new chairman of the board of directors, effective October 1, 2024. The current CEO and board member Rikard Akhtarzand will serve as interim chairman of the board from September 1, 2024, until the new chairman assumes office on October 1, 2024. Staffan Torstensson will step down from his position as a board member in conjunction with his appointment as CEO.
Oliver Humlen, the company's CFO and former incoming CEO has been notified of a suspected minor drug offense, which he denies. No other employee at ADDvise has attended the same event or is under suspicion. The board of directors is taking this situation seriously and has concluded that there is no basis for continued trust considering the suspicion. As a result, the board of directors has decided to terminate his employment effective immediately.
The search for a new CFO is ongoing and proceeding as previously communicated. Johan Irwe, currently VP Finance at ADDvise, will serve as interim CFO, effective immediately until a new CFO is appointed.
Staffan Torstensson has served as member and chairman of the board of directors of the company for 10 years. Staffan has over 20 years of experience in investment banking, mergers and acquisitions, and board assignments in listed companies, Staffan's most recent position is the position of partner at Corporate Finance, Evli AB. Staffan is a board member in Tuida Holding AB, GB Tennis AB and Glase Energy AB. Per Åhlgren is the largest shareholder of ADDvise and has extensive experience with listed companies. He currently serves as chairman of the board of directors of Bong AB and Mangold Fondkommission and board member in Vestum AB.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 (0) 76-525 90 71
rikard.akhtarzand@advisegroup.se
Staffan Torstensson, chairman of the board of directors
+46 (0) 70-433 20 19
Important information
This information is such that ADDvise Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on July 17, 2024, at 19:45 CEST.
About ADDvise
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the company's Certified Adviser. More information is available at www.addvisegroup.com.